XOMA Co. (NASDAQ:XOMAO) Sees Significant Decline in Short Interest

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 1,159 shares, a drop of 46.1% from the May 31st total of 2,149 shares. Based on an average daily volume of 3,451 shares, the days-to-cover ratio is presently 0.3 days.

XOMA Price Performance

NASDAQ XOMAO traded up $0.02 during trading hours on Wednesday, reaching $25.47. The stock had a trading volume of 763 shares, compared to its average volume of 4,166. The stock has a fifty day moving average of $25.35 and a 200 day moving average of $25.42. XOMA has a 52-week low of $24.86 and a 52-week high of $26.40.

XOMA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 14th. Stockholders of record on Thursday, July 2nd will be issued a $0.5234 dividend. This represents a $2.09 annualized dividend and a dividend yield of 8.2%. The ex-dividend date of this dividend is Thursday, July 2nd.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early?stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.